Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Annual MeetingFull Access

Learn the Latest On Alcohol Research

Published Online:21 Apr 2006https://doi.org/10.1176/pn.41.8.0025

The National Institute on Alcohol Abuse and Alcoholism is collaborating with APA on a special track of sessions at the 2006 annual meeting next month in Toronto. The track will feature symposia, workshops, forums, and lectures by some of the world's leading scientists. In addition to stressing the development of clinical knowledge and skills, these sessions will highlight important new findings in epidemiology, genetics, neuroscience, prevention, and treatment.

Monday, May 22

9 a.m.-10:30 a.m.

Issue Workshop 3

Managing Complex Comorbid Psychiatric and Alcohol Use Disorders in Psychiatric Practice

Toronto Convention Centre, North Level 200, Room 206 E/F

11 a.m.-12:30 p.m.

Research Consultation

Clinical Research on Alcohol Use Disorders

Intercontinental Hotel, Main Level, Oakville Room

Noon-1:30 p.m.

Forum 4

Women and Alcohol Use Disorders

Toronto Convention Centre, South Level 800, Room 801 B

2 p.m.-5 p.m.

Symposium 13

Substance Use Disorders in the U.S.

Toronto Convention Centre, South Level 700, Room 713 A/B

Prevalence and Correlates of Prescription Drugs Nonmedical Use and Use Disorders In the United States: 1991-1992 and 2001-2002

Alcohol and Drug Dependence and the Specificity of Family History

Prevalence, Correlates, and Comorbidity of DSM-IV Drug Use Disorders

Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

The Relationship of Family History to Cocaine and Cannabis First Use and Dependence

Symposium 26

Taking Science to Policy: Efforts to Reduce Harms Related to Alcohol Misuse

Royal York, Mezzanine Floor, Manitoba Room

The Magnitude and Prevention of Underage Drinking Problems

Pragmatic Science: The New NIAAA Clinician's Guide

Alcohol Interventions in Trauma Centers Reduce Reinjury Rates: State Laws and Insurance Regulations Prevent Their Implementation

Implementing Alcohol Treatment for People With Co-Occurring Disorders In Psychiatric Treatment Settings

What Kind of Treatment System Is Necessary to Implement Evidence-Based Practices?

Tuesday, May 23

9 a.m.-10:30 a.m.

Lecture 13

What Have We Learned About Alcoholism From Animal Models?

Toronto Convention Centre, South Level 700, Room 718 A/B

Ting-Kai Li, M.D., Director, National Institute on Alcohol Abuse and Alcoholism

Issue Workshop 40

Practical Pharmacotherapy for the Treatment of Alcohol Dependence

Toronto Convention Centre, South Level 700, Room 717 B

Noon- 1:30 p.m.

Forum 11

The Future of Alcohol Research: NIAAA Resident Travel Award Winners With Discussion by a Panel of Senior Researchers

Royal York, Mezzanine Floor, Territories Room

2 p.m.- 3:30 p.m.

Frontiers of Science Lecture 18

Pharmacogenetics of Alcohol: Are We There Yet?

Toronto Convention Centre, North Level 300, Exhibit Hall A Henry R. Kranzler, M.D.

Frontiers of Science Lecture 19

An Evidence-Based Clinician's Guide to the New Pharmacotherapies for Alcoholism

Toronto Convention Centre, South Level 700, Room 718 A/B Barbara J. Mason, Ph.D.

2 p.m.- 5 p.m.

Symposium 38

Screening, Diagnosis, and Management of Alcohol Use Disorders in Psychiatric Practice

Toronto Convention Centre, North Level 200, Room 206 E/F

Screening, Assessment, and Management Using the NIAAA Clinician's Guide

Motivational Enhancement Strategies to Address Substance Use Disorders

Integrating Pharmacotherapy for Alcohol Dependence Into General Psychiatric Practice

Meeting the Addiction Medicine Needs of Patients in a General Psychiatric Practice

Symposium 48

Substance Use Disorders: Planning a Research Agenda for DSM-V

Toronto Convention Centre, South Level 700, Room 716 A

Adolescents and Substance Related Disorders: Research Agenda to Guide Decisions on DSM-V

Methods for DSM-V Research Work Groups to Address Key Diagnostic Issues for Substance Use Disorders

Substance Use Disorder Comorbidity and DSM-V

What Can Human Brain Imaging Tell Us About Addiction?

Symposium 59

Genetic Findings Related to Alcohol Dependence and Related Conditions

Royal York, Mezzanine Floor, Quebec Room

Genetic Susceptibility for Alcohol Dependence: Recent Findings

At Risk Families: A Multigenerational Study of Alcoholism

Further Characterization of the Risk Associated With GABA-A Receptor Genes

Neurophysiological Endophenotypes and the Risk for Alcohol Dependence and Related Disorders

Prediction of Alcohol Problems Using a Prospective Longitudinal Design Including Genotype

Wednesday, May 24

9 a.m.-10:30 a.m.

Lecture 21

Combining Neuroimaging and Pharmacology To Better Treat Alcoholism?

Toronto Convention Centre, North Level 300, Exhibit Hall A Karl F. Mann, M.D.

9 a.m.-noon

Media Presentation Workshop 6

Carter's Addiction: Substance Use Disorders in Physicians

Royal York, Mezzanine Floor, Quebec Room

11 a.m.-12:30 p.m.

Lecture 24

A University President's Perspective on Alcohol Related Research

Toronto Convention Centre, North Level 300, Exhibit Hall A Rev. Edward Malloy, C.S.C., President Emeritus, University of Notre Dame

Lecture 25

Beyond Dopamine: Neuroadaptations, Negative Affect, and Clinically Relevant Treatment Targets in Alcoholism

Toronto Convention Centre, South Level 700, Room 718 A/B Markus Heilig, M.D.

11 a.m.- 12:30 p.m.

Issue Workshop 68

Applying for National Institute on Alcohol Abuse and Alcoholism Research Money: Some Things You Didn't Learn in Graduate School

Toronto Convention Centre, South Level 700, Room 709

2 p.m.-3:30 p.m.

Lecture 26

Medications That Act at Ion Channels as Treatment for Alcohol Dependence

Toronto Convention Centre, North Level 100, Room 105 Bankole A. Johnson, M.D., Ph.D.

2 p.m.-5 p.m.

Symposium 66

Risk Factors, Personality Variables, and Addictive Disorders

Toronto Convention Centre, North Level 100, Room 104 A

Risk Factors for Addictive Disorders

Dependency and Suicidality in Addictive Disorders

Depressive Psychopathology in Addictive Disorders

Sensation Seeking and Addictive Disorders

Addictive Disorder: Goodman's Concept of Addiction, A Study of 692 Addictive Subjects

Symposium 82

Adolescent Alcohol Use Disorders and Psychiatric Comorbidity

Toronto Convention Centre, South Level 700, Room 716 A

Trauma and Alcohol Use Disorders in Adolescents: Psychiatric Comorbidity and Adult Outcomes

Assessing Alcohol Problems in Adolescents With Psychiatric Comorbidity

Treatment of Adolescents With Alcohol Problems and Major Depression

When ADHD and Substance Use Disorders Collide

Symposium 87

Alcohol, Drugs, and Psychiatric Disorders in the U.S.

Toronto Convention Centre, South Level 800, Room 801 B

Comorbidity of Pain and Substance Use Disorders in the U.S.

Antisocial Personality Disorder and Lifetime Course of Alcohol Use Disorders in the U.S. General Population

Prevalence, Correlates, and Comorbidity of Alcohol Use Disorders in the U.S.

Prevalence, Correlates, and Comorbidity of Nonmedical Sedative, Tranquilizer, Opioid, and Amphetamine Use, Abuse, and Dependence in the U.S.

Cannabis Withdrawal Syndrome in 2,613 Lifetime Heavy Cannabis Users From a National Survey: Symptom Prevalence, Factor Structure, and Correlates

Symposium 88

Sobering Facts: Alcohol Dependence and Treatment Interventions

Toronto Convention Centre, South Level 800, Room 803 A/B

The Impact of Alcohol Use Disorders

Alcohol Dependence: Difficulties in Diagnosis

Integrating Pharmacotherapy and Psychosocial Support in Treating the Alcohol-Dependent Patient

Pharmacotherapy for the Treatment of Alcohol Dependence: Review of Outcome Data

Symposium 97

Translating the Neurobiology of Alcoholism Into Clinical Treatments

Royal York, Convention Floor, Ballroom

Lost in Translation: Preclinical Studies of Genetic Susceptibility and Neuroadaptations Point to a Growing List of Novel Candidate Targets for Treatment of Alcoholism

Medications for Treating Alcoholism: From Animal Models to Clinical Usefulness

Animal Models for Novel Medications for Alcoholism: View From the Dark Side

Alcohol Relapse-Like Behavior in Laboratory Animals: The Nociceptin/Orphanin Fq System: A Potential Target for the Development of New Pharmacotreatments

Development of a Human Laboratory Model of Risk Factors for Relapse in Alcohol Dependence, Implications for Predicting Medication Efficacy in Clinical Trials

Thursday, May 25

11 a.m.-12:30 p.m.

Issue Workshop 99

Disasters, Public Policy, and Addiction Psychiatry

Toronto Convention Centre, North Level 200, Room 206 C/D

Issue Workshop 102

Medical Comorbidity in Dual-Diagnosis Patients

Toronto Convention Centre, South Level 700, Room 705